European Journal of Molecular & Clinical Medicine

Abstract

According to WHO, Osteoporosis is second only to cardiovascular disease as a global
healthcare problem. International Osteoporosis Foundation (IOF) estimates that the annual
direct cost of treating osteoporosis fractures of people in the workplace in the USA, Canada
and Europe alone is approximately USD48 billion. The present study comprises of clinically,
diagnostically confirmed cases of Postmenopausal Osteoporosis both Diabetics and Non-
Diabetics and attending the orthopaedic unit of KLES Dr. Prabhakar Kore Hospital and
Medical Research Centre, Belagavi. All the cases were evaluated and selected by simple
random technique after fulfilling the selection criteria. The cases of Osteoporosis reported to
the Department of Orthopaedics unit of KLES Hospital and Medical Research Center were
screened. After finding the suitability as per selection criteria they were requested to
participate in the study and briefed about the nature of the study and interventions used. The
mean serum calcium for diabetics was 8.22±1.13 mg/dL and for non-diabetics was 8.4 ± 1.27
mg/Dl. The mean serum calcium levels were lower in Diabetics but was not statistically
significant (p=0.5564 for calcium).